About Innophos
Innophos is a company based in Cranbury (United States) founded in 2004 was acquired by One Rock Capital Partners in October 2019. Innophos has completed 4 acquisitions, including Kelatron, Novel Ingredient and NutraGenesis. Innophos offers products and services including Specialty Phosphates and Chelated Minerals.
- Headquarter Cranbury, United States
- Stage Public
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Innophos
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Kelatron
& 3 more
-
Acquired by
One Rock Capital Partners
(Oct 21, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Innophos
Innophos offers a comprehensive portfolio of products and services, including Specialty Phosphates and Chelated Minerals.
Specialty phosphates are produced for use in food, health, and industrial applications, including baking and nutrition enhancements.
Chelated minerals are developed to support health and nutrition, such as chelamax minerals that are utilized in dietary supplements and pharmaceuticals.
People of Innophos
Unlock access to complete
Unlock access to complete
Software Development Team
17 people
Leadership Team
16 people
Human Resources and Administration
10 people
Finance and Accounting
9 people
Process Team
9 people
Sales and Marketing
9 people
Senior Team
5 people
Product Management Team
4 people
Unlock access to complete
Funding Insights of Innophos
Investors in Innophos
Innophos has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include One Rock Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
A private equity firm focused on value creation is operated.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Innophos
Innophos has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Kelatron, Novel Ingredient and NutraGenesis.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Clinically tested nutraceutical ingredients are developed and supplied globally.
|
2002 | ||||
|
Nutraceutical ingredients are manufactured and marketed by Novel Ingredient.
|
1995 | ||||
|
Chelated minerals and premixes are manufactured for nutritional industries.
|
1985 |
Financial Statements - Innophos
Innophos Comparisons
Competitors of Innophos
Latest news on Innophos
Frequently Asked Questions about Innophos
Innophos was founded in 2004.
Innophos is headquartered in Cranbury, United States. It is registered at Cranbury, New Jersey, United States.
Innophos was founded in 2004 and is headquartered in Cranbury, United States. Operations focus on the production of specialty phosphates, chelated minerals, and nutritional ingredients for applications in food and beverage, health and nutrition, and industrial sectors. Phosphate blends and mineral products are developed to meet customer requirements. Manufacturing processes are maintained for quality and supply chain reliability, with research and development supporting product innovation.
Innophos offers Specialty Phosphates and Chelated Minerals.
Innophos has made 4 acquisitions, including Kelatron, Novel Ingredient, and NutraGenesis.
Innophos has 1 investor. Key investors include One Rock Capital Partners.